Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DELTA 3 Extension Trial of Delgocitinib for Chronic Hand Eczema
NCT04949841Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Aug 2021
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of delgocitinib in chronic hand eczema (CHE), sponsored by LEO Pharma. Started Aug 2021; status: completed.
02
Drugs
delgocitinib
03
Conditions
chronic hand eczema (CHE)
Beyond the preview
Go deeper on NCT04949841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04949841.